InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,467.02
(
-0.04%
)
US TECH 100
19,196.60
(
0.11%
)
Dow Jones
39,151.70
(
0.10%
)
Brent Oil
84.55
(
0.43%
)
Bitcoin
61,223.73
(
-0.95%
)
Post# of 1367
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: None

Friday, 03/30/2007 1:57:47 PM

Friday, March 30, 2007 1:57:47 PM

Post# of 1367
Quark Biotech known as QBI, files for IPO at Nasdaq. CEO Daniel Zurr said last month they want to raise $70 at a value of $300.


Quark Biotech, which develops RNA interference-based therapeutics for the treatment of diseases associated with oxidative stress, filed for IPO Friday. JPMorgan and Banc of America are bookrunning the deal. Terms have not yet been announced.

http://www.ipohome.com/common/ipoprofile.asp?ticker=QURK

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up